Perspective on Hepatitis C

As a hepatitis C virus (HCV) sufferer and a former health care worker, I would like to offer your readers some information from the perspective of a patient with HCV for more than 20 years. HIV has drawn all the attention, while 4-5 million people suffer from HCV. Why no help from the media? Once the liver is destroyed, our immune systems get compromised. The full effects of this virus are yet to be seen in our society. Methadone clinic patients are testing positive at an alarming rate for this

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

As a hepatitis C virus (HCV) sufferer and a former health care worker, I would like to offer your readers some information from the perspective of a patient with HCV for more than 20 years. HIV has drawn all the attention, while 4-5 million people suffer from HCV. Why no help from the media? Once the liver is destroyed, our immune systems get compromised. The full effects of this virus are yet to be seen in our society. Methadone clinic patients are testing positive at an alarming rate for this virus. Health care workers are not being properly monitored, and the Centers for Disease Control and Prevention only wants new cases reported to them, yet 80-90 percent of HCV sufferers are considered chronic.

Why are dentists, police, and fire departments, including paramedic rescue teams, not adequately educated about protecting themselves from this virus? What about the issues of liver transplants ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Kevin Donnelly

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo